Literature DB >> 29467219

Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia: Connecting the Dots.

Raul D Santos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29467219     DOI： 10.1161/ATVBAHA.117.310675

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  3 in total

Review 1.  Beyond Statins and PCSK9 Inhibitors: Updates in Management of Familial and Refractory Hypercholesterolemias.

Authors:  Fabiana Rached; Raul D Santos
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

Review 2.  Lomitapide and Mipomersen-Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis.

Authors:  Dirk J Blom; Frederick J Raal; Raul D Santos; A David Marais
Journal:  Curr Atheroscler Rep       Date:  2019-11-19       Impact factor: 5.113

Review 3.  Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia.

Authors:  Claudia Stefanutti
Journal:  Curr Atheroscler Rep       Date:  2020-06-18       Impact factor: 5.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.